An interventional study of Detection of TNFAIP3 gene expression by real time PCR. in Ankylosing Spondylitis and Psoriatic Arthritis Patients, sponsored by Asmaa Hassan mohamed Abdel Mawjoud. Not yet recruiting. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-02.
Sponsored by Asmaa Hassan mohamed Abdel Mawjoud · Not applicable, Interventional, and Diagnostic
Inclusion criteria:
Patients diagnosed with psoriatic arthritis (PsA patients (age ≥18 years) who fulfilled the CASPAR classification criteria for PsA 2010) (11).
b. Exclusion criteria: Patients with erythrodermic or pustular psoriasis, pregnant and lactating females, patients with autoimmune diseases e.g. systemic lupus erythematosus, or major systemic diseases, and patients receiving any immunosuppressive drug will be excluded from the study.
498 studies on the registry are indexed under Spondylitis, Ankylosing; 89 are open to participants now.
This study's planned enrollment of 110 is above the median of 84 across 275 interventional studies indexed under Spondylitis, Ankylosing.
Browse Spondylitis, Ankylosing studies →Asmaa Hassan mohamed Abdel Mawjoud is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
- 1. Patients diagnosed with ankylosing spondylitis according to Modified New York classification criteria 1984.
2. Patients diagnosed with psoriatic arthritis (PsA patients (age ≥18 years) who fulfilled the CASPAR classification criteria for PsA 2010)
Exclusion Criteria:
Diagnostic Test: Detection of TNFAIP3 gene expression by real time PCR.
Diagnostic Test: Detection of TNFAIP3 gene expression by real time PCR.
Detection of TNFAIP3 gene expression by real time PCR.
Detection of TNFAIP3 gene expression. Ankylosing spondylitis (AS) is a chronic inflammatory condition primarily affecting the axial bone and sacroiliac joints. Its etiology involves genetic, environmental variables and demographic factors .
Time frame: 18 months
Detect relation between TNFAIP3 and ankylosing spondylitis apsoriatic arthritis activity. detection of TNFAIP3 gene expression by real time PCR will be done for every subject.
Time frame: 20 months
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Asmaa Hassan mohamed Abdel Mawjoud